Rifaximin to Modify the Disease Course in Sickle Cell Disease
Clinical trial NCT03719729 · UNKNOWN
Trial details
- NCT number
- NCT03719729
- Sponsor
- New York Medical College
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-22
- Primary completion
- 2020-02-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.